PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer | The NEW ENGLAND JOURNAL Of MEDICINE

Authors: Andrea Cercek, M.D., Melissa Lumish, M.D. https://orcid.org/0000-0003-4173-5567, Jenna Sinopoli, N.P., Jill Weiss, B.A., Jinru Shia, M.D., MichelleLamendola-Essel, D.H.Sc., Imane H. El Dika, M.D., and Luis A. Diaz, Jr., M.D.

BACKGROUND

Neoadjuvant chemotherapy and radiation followed by surgical resection of the rectum is a standard treatment for locally advanced rectal cancer. A subset of rectal cancer is caused by a deficiency in mismatch repair. Because mismatch repair–deficient colorectal cancer is responsive to programmed death 1 (PD-1) blockade in the context of metastatic disease, it was hypothesized that checkpoint blockade could be effective in patients with mismatch repair–deficient, locally advanced rectal cancer.

METHODS

We initiated a prospective phase 2 study in which single-agent dostarlimab, an anti–PD-1 monoclonal antibody, was administered every 3 weeks for 6 months in patients with mismatch repair–deficient stage II or III rectal adenocarcinoma. This treatment was to be followed by standard chemoradiotherapy and surgery. Patients who had a clinical complete response after completion of dostarlimab therapy would proceed without chemoradiotherapy and surgery. The primary end points are sustained clinical complete response 12 months after completion of dostarlimab therapy or pathological complete response after completion of dostarlimab therapy with or without chemoradiotherapy and overall response to neoadjuvant dostarlimab therapy with or without chemoradiotherapy.
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer

RESULTS

A total of 12 patients have completed treatment with dostarlimab and have undergone at least 6 months of follow-up. All 12 patients (100%; 95% confidence interval, 74 to 100) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging, 18F-fluorodeoxyglucose–positron-emission tomography, endoscopic evaluation, digital rectal examination, or biopsy. At the time of this report, no patients had received chemoradiotherapy or undergone surgery, and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months). No adverse events of grade 3 or higher have been reported.

CONCLUSIONS

Mismatch repair–deficient, locally advanced rectal cancer was highly sensitive to single-agent PD-1 blockade. Longer follow-up is needed to assess the duration of response. (Funded by the Simon and Eve Colin Foundation and others; ClinicalTrials.gov number, NCT04165772.)
Locally advanced rectal cancer is typically managed with multimodal therapy, including chemotherapy, radiation, and surgery. Current evidence supports a strategy involving the use of neoadjuvant therapy, in which induction chemotherapy with a fluoropyrimidine in combination with oxaliplatin is followed by chemoradiotherapy and then surgery.1-3 This approach results in a pathological complete response in up to a quarter of patients, but it is associated with marked complications and toxic effects — including bowel, urinary, and sexual dysfunction; infertility; and altered quality of life — in a substantial proportion of patients.4-6 In patients undergoing surgery, resection of the rectum is life-altering and often warrants a permanent diverting colostomy.6,7 Owing to the complications of surgery and the high frequency of pathological complete response, interest in organ-sparing nonoperative management is increasing. The use of clinical complete response that is achieved with neoadjuvant treatment as a surrogate for pathological complete response provides patients with a nonoperative option that results in a survival benefit that is similar to that in patients undergoing surgical resection.8-11
Approximately 5 to 10% of rectal adenocarcinomas are mismatch-repair deficient, and these tumors have been shown to respond poorly to standard chemotherapy regimens, including neoadjuvant chemotherapy in locally advanced rectal cancer.12-14 Immune checkpoint blockade alone has been shown to be highly effective as first-line treatment for patients with mismatch repair–deficient metastatic colorectal cancer, as well as for patients with treatment-refractory disease, with objective response rates of 33 to 55%, clinically significant durability of response, and prolonged overall survival.15-17
On the basis of the benefits seen in the context of metastatic disease, we hypothesized that single-agent programmed death 1 (PD-1) blockade alone might be beneficial in mismatch repair–deficient, locally advanced rectal cancer. To test this hypothesis, we initiated a phase 2 study to investigate the overall response and frequency of sustained clinical complete response to neoadjuvant treatment with dostarlimab, a PD-1 inhibitor, in this patient population.

Skip The Scoop | Seek Understanding

Murder Suspect Mistakenly Released in NYC

Show Me

90,000 Ballots in Largest Nevada County Sent to Wrong Addresses, Bounced Back: Report

Show Me

The Progressive Democratic Steamroller

Show Me

Hong Kong’s Illusionist

Show Me

Thousands of Orthodox Jews participated in a COVID-19 study last year. The first results are in.

Show Me

Wisconsin state Senator wants Green Bay mayor to resign over handling of November election

Show Me

Alaska becomes first state to allow COVID-19 vaccination residents 16 and older

Show Me

Senate confirms Merrick Garland as Biden’s Attorney General

Show Me

Texas Lifts State Mask Mandate Among Other Restrictions as Pandemic Sees Downward Trend

Show Me

Criticizing Public Figures, Including Influential Journalists, is Not Harassment or Abuse

Show Me

House Passes Biden’s $1.9 Trillion COVID-19 Relief Package

Show Me

GOP Rep. Reed: Biden’s bill sends $1,400 stimulus checks to ‘convicted child molesters’ in prison

Show Me

40 House Republicans Join Democrats to Reject Greene’s Efforts to Delay Stimulus Package

Show Me

Judicial Watch Sues CDC for Communications with Big Tech on COVID-19

Show Me

Virginia state investigator alleges intimidation by Democratic Governor Northam’s staff

Show Me

Bannon’s War Room | Morning Edition Hour 1 | Recorded March 10, 2021 | Video: 48 Minutes 36 Seconds

Show Me

Bannon’s War Room | Morning Edition Hour 2 | Recorded March 10, 2021 | Video: 48 Minutes 28 Seconds

Show Me

Brewpubs and Restaurants Sue Kentucky Governor Over COVID-19 Restrictions

Show Me

Bannon’s War Room | Evening Edition | Recorded March 10, 2021 | Video: 48 Minutes 58 Seconds

Show Me

It Appears The Children’s Defense Fund Broke The Law & Blatantly Violated It’s 501(c)(3) Restrictions

Show Me

Arkansas Governor Signs Pro-Life Bill Into Law That Bans Most Abortions

Show Me

March 9, 2021 | Nightly News Rebroadcast | Video: 50 Minutes 23 Seconds

Show Me

FBI Video Of Suspect Planting Pipe Bomb Night Before Capitol Riot

Show Me

Pfizer Demands Nations Put Up Collateral to Cover Vaccine Injury Lawsuits

Show Me

Republican National Committee to hold part of annual donor retreat at Trump’s Mar-a-Lago

Show Me

Republican National Committee won’t comply with Trump order to stop using his name, likeness

Show Me

Bannon’s War Room | Morning Edition Hour 1 | Recorded March 9, 2021 | Video: 48 Minutes 29 Seconds

Show Me

Publisher halts Cuomo book promotion, citing nursing home inquiry

Show Me

Arizona and Montana Take Legal Action Against Biden Admin ICE Arrest Regulations

Show Me

BREAKING: Massive 100,000 Migrants Flooded U.S. Border in Just 4 Weeks.

Show Me

Bannon’s War Room | Morning Edition Hour 2 | Recorded March 9, 2021 | Video: 48 Minutes 37 Seconds

Show Me

Number of migrant children detained on southern U.S. border has tripled over past two weeks

Show Me

Tesla Loses More Than $244 Billion in a Month as Rally Fizzles

Show Me

Bannon’s War Room | Evening Edition | Recorded March 9, 2021 | Video: 48 Minutes 58 Seconds

Show Me

Judicial Watch Sues for Records of Pelosi Call with Pentagon Chief

Show Me

Chinese Communist Party Violating Every Act Of Genocide Convention New Legal Report Finds.

Show Me

More Media Bias on Guns: CBS’s Magnum PI shows that supposedly if only a gun hadn’t sold a gun illegal man couldn’t have attempted suicide

Show Me

Iowa Governor Signs Bill to Limit Absentee and Early Voting, Close Polls Earlier

Show Me

South Dakota Senate Passes Bill to Ban Biological Males in Girls’ Sports

Show Me

High Schools to Reopen in New York City

Show Me